 |
HUVEC Transfection Reagent |
|
|
Catalog # 4106 - 0.5 mL $ 97.00
Catalog # 4107 - 1.5 mL $ 224.00
Transfection reagent for HUVEC cells
- Protocols provided for transfection of mRNA, siRNA and microRNA
- Transfection Enhancer reagent included
- Optimized for umbilical vein endothelial cells
- High cell viability
- Work in presence of serum
- Reproducible transfection
- Works well for reverse transfection and high throughput protocols
- Developed and manufactured by Altogen Biosystems
Transfection Efficiency:
Reagent exhibits at least 80% transfection
efficiency of siRNA delivery. Transfection efficiency
was determined by real-time RT-PCR.
Transfection Protocol:
Transfection protocols are provided with
the purchase of the reagent.
|
 |
DATA |
|
Figure 1. GAPD mRNA levels were quantified using real-time RT-PCR in the cells transfected with siRNAs targeting GAPD or non-silencing siRNA. Forty-eight hours post-transfection, the cells were harvested and analyzed by real-time RT-PCR for GAPDH mRNA expression levels. Data were normalized against the 18S rRNA signal. Control samples were either mock-transfected or untreated. Values are normalized to untreated sample. Data are means ± SD (n=3).
 |
HUVEC Cells |
|
Human Umbilical Vein Endothelial Cells HUVEC are isolated from human umbilical vein. Endothelial cells play a key role in a diverse range of physiological processes (such as angiogenesis) and pathophysiological processes (including arterial disease and cancer development). HUVEC systems are commonly used for physiological and pharmacological investigations, such as macromolecule transport, fibrinolysis, and blood coagulation. HUVEC are normally responsive to cytokine stimulation in the expression of cell adhesion molecules.
 |
Transfection Resource |
|
siRNA Transfection || Transfection Methods || Stable Transfection || RNAi || siRNA Library Screening || RNAi Therapeutics || Cell Transfection || In Vivo Transfection Reagents || Cell Line Specific Transfection Reagents
 |
Featured Products |
|
In Vivo Transfection Reagents || Fibroblast Cells Transfection Reagent || Astrocyte Cells Transfection Reagent || HEK-293 Transfection Reagent || MEF Transfection Reagent || HepG2 Transfection Reagent || CHO Reagent || MDA-MB Transfection Reagent || Cos7 Transfection Reagent || A549 Transfection Reagent || NIH3T3 Reagent || HUVEC Transfection Reagent || LNCaP Transfection Reagent || MCF-7 Reagent || PC-12 Reagent
 |
Altogen Research Services |
|
Altogen Custom Services provide specialized biotechnology and pharmaceutical services, including - generation of stable cell lines, RNA Interference (RNAi) services, assay development, screening and transfection services. Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Altogen Services offers generation of stable cell lines by transforming the cell line of choice to stably express gene of interest or shRNA-encoding construct. Cloning and shRNA expression services are available.
|